Northern Trust Corp Rvl Pharmaceuticals PLC Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.08 - $0.55 $605 - $4,160	-7,565 Reduced 10.38%	65,334 $5,000
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.61 $8,595 - $13,567	8,427 Added 13.07%	72,899 $81,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $2.91 $8,472 - $19,261	-6,619 Reduced 9.31%	64,472 $135,000
Q2 2022 Aug 12, 2022	SELL	$1.21 - $1.81 $4,670 - $6,986	-3,860 Reduced 5.15%	71,091 $97,000
Q1 2022 May 13, 2022	BUY	$1.03 - $2.01 $30,447 - $59,417	29,561 Added 65.13%	74,951 $127,000
Q4 2021 Feb 08, 2022	BUY	$0.98 - $3.06 $18,848 - $58,852	19,233 Added 73.53%	45,390 $49,000
Q2 2021 Aug 13, 2021	SELL	$2.8 - $3.78 $331,455 - $447,465	-118,377 Reduced 81.9%	26,157 $79,000
Q1 2021 May 12, 2021	SELL	$3.26 - $4.84 $53,369 - $79,235	-16,371 Reduced 10.17%	144,534 $472,000
Q4 2020 Feb 11, 2021	SELL	$4.12 - $6.29 $7,514 - $11,472	-1,824 Reduced 1.12%	160,905 $663,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $8.77 $334,454 - $608,541	69,389 Added 74.34%	162,729 $881,000
Q2 2020 Aug 14, 2020	SELL	$2.83 - $6.99 $102,949 - $254,282	-36,378 Reduced 28.04%	93,340 $628,000
Q1 2020 May 14, 2020	BUY	$3.18 - $7.0 $97,155 - $213,864	30,552 Added 30.81%	129,718 $413,000
Q4 2019 Feb 14, 2020	BUY	$3.46 - $7.7 $39,295 - $87,448	11,357 Added 12.93%	99,166 $693,000
Q3 2019 Nov 13, 2019	SELL	$2.8 - $3.99 $32,591 - $46,443	-11,640 Reduced 11.7%	87,809 $337,000
Q2 2019 Aug 13, 2019	BUY	$2.34 - $4.28 $12,238 - $22,384	5,230 Added 5.55%	99,449 $378,000
Q1 2019 May 13, 2019	BUY	$3.6 - $8.75 $53,125 - $129,123	14,757 Added 18.57%	94,219 $340,000
Q4 2018 Feb 12, 2019	BUY	$6.25 - $9.2 $496,637 - $731,050	79,462 New	79,462 $615,000

Others Institutions Holding RVLP

# of Institutions

Shares Held

92.5K

Call Options Held

Put Options Held

Titleist Asset Management, Ltd. San Antonio, TX

92.5K
Shares

$0
0.02% of portfolio

View Full List

About RVL Pharmaceuticals plc

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

More about RVLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account